Did you know CAG results after OHCA? 🚑🫀
Do not waste another second and run to read our article just published!
#CAG#OHCA@ResusJournal
https://t.co/koZzsDIfzW
How do we measure the severity of Mitral Regurgitation (MR)? Enter the PISA method.
1/
PISA = Proximal Isovelocity Surface Area
It's a hemispheric zone of blood flow seen on color Doppler as it rushes toward a leaky mitral valve. The faster the flow, the more curved (and larger) this shell becomes.
2/
By adjusting the Doppler baseline toward the MR jet, we get a clearer PISA "dome." Measure the radius (r) of this dome—from the valve to the first color change (aliasing point).
3/
Use this formula to calculate the size of the leaky opening:
EROA = (2πr² × Valiasing) / Vmax(MR jet)
EROA = Effective Regurgitant Orifice Area
A larger EROA = more severe MR.
4/
To calculate how much blood is leaking:
Regurgitant Volume = EROA × VTI(MR)
(VTI = total flow over time from the MR jet)
5/
Why it matters:
- Helps assess MR severity
- Guides treatment decisions
- Combines well with other echo findings
#Echo #Cardiology #PISA #MitralRegurgitation #CardioTwitter
Awake #ECMO in adults with respiratory failure, SR
📈 feasible & low failure risk in selected patients
🫁 mostly investigated in BT lung #transplantation (acceptable success), experimental in #ARDS
🫁 worsening respiratory failure, #delirium/agitation, bleeding most common reasons for failure; mortality almost 60% in patients who failed
📉 complications rate poorly reported
📖 https://t.co/JwZovOzNMd
With editorial on physiology-based indications to improve outcome of awake #ECLS
📖 https://t.co/wSXzlD42sA
#ICUrehab @CritCareMed
1/3
We assessed feasibility and safety of awake #ECMO without invasive ventilation in patients with severe respiratory failure
467 awake ECMO patients from 57 manuscripts are described in this article
🔗 Just published in @CritCareMed: https://t.co/hhUTTZcUk8
#FOAMcc
WHAT ARE THE FINDINGS OF CAG AFTER OHCA?🫀
We performed a SRMA of 128 studies (>62k pts) to describe angiographic features in resuscitated and refractory OHCAs
We found that
🔸 significant CAD is present in 75%
🔸 CAD is more severe in refractory OHCA
🔸 CAD is common also in pts with non-shockable rhythms and without ST↑
📄 Just published @ResusJournal https://t.co/A8YT90A5XB
🧵 Learn more in the thread 👇
#ResusTwitter #CardioTwitter #FOAMcc
our Gianvito Martino @SanRaffaeleMI@MyUniSR published in @NatureMedicine a phase I study on #MultipleSclerosis safely intrathecally injecting neural precursor cells
Interestingly, high dose neural cells was associated with lower rate of brain atrophy
https://t.co/kiPzACayrE
Left ventricular longitudinal #strain could differentiate the prognosis after CABG in patients with preserved LVEF and provide significant incremental prognostic value to LVEF. https://t.co/0Wpnq8Tjlp
More patients in the high dosing #PROTAMINE group received plasma (11 % vs 0 %; p=0.02) and platelet concentrate (21 % vs 6 %; p=0.04) compared to the low dosing #PROTAMINE group.
Abundant protamine dosing increased postoperative blood loss
https://t.co/EK8ixVbl2n
@MattDelNin @Dan_Landry@DrToddLee@BradSpellberg I think a correct approach should be "full anticoagulation in #covid19 outside the ICU, if the physician does not perceive increased bleeding risk"
this is the phylosophy behind it https://t.co/ITRXo0QELX
and this is the EBM
https://t.co/FNowdLm0fg
@DrToddLee
Evidence is accumulating that full anticoagulation in #covid19#icu patients is not beneficial for survival https://t.co/iIAA48MMc5
Please remember that evidence is accumulating that full anticoagulation in #covid19 patients outside the ICU is beneficial for survival
Validation of awake calibration of TOF monitoring
⚖️Awake calibration on one arm before anesthesia induction vs. anesthetized calibration on the other arm
🤝Close agreement in the duration to normalization between awake and anesthetized calibration
🔗https://t.co/DL7r29kg5D
Our article is out.
Will we find a way to protect the kidneys and prevent #AKI with continuous infusion of amino acids?
We’ve already randomized 2000/3500 patients in 16 centers.
🔗 https://t.co/USmDq9ZMoh #PROTectionTrial#FOAMcc
https://t.co/QlO0Ydeef7